Adicet Bio, Inc

Ironwood Pharmaceuticals, headquartered in Boston, Massachusetts, is a biotechnology company dedicated to developing and commercializing innovative therapies for individuals suffering from gastrointestinal and rare diseases. The company is recognized for its pioneering work on LINZESS, a leading prescription treatment for adults with irritable bowel syndrome with constipation and chronic idiopathic constipation, as well as its ongoing research into apraglutide for short bowel syndrome patients. Founded in 1998, Ironwood Pharmaceuticals places a strong emphasis on patient-centered research and development, aiming to alleviate the burden of gastrointestinal diseases and address significant unmet medical needs. With a commitment to innovation, the company strives to improve the quality of life for millions of patients affected by these conditions. Generated from the website

Solvo Biotechnology USA Inc, based in Boston, MA, is a pioneer in the drug transporter field, dedicated to advancing the science of transporters and their role in xenobiotic efficacy and safety. As a part of Charles River Laboratories, the company aims to be a globally recognized leader in providing high-quality products and services related to ADME Tox transporters. With a commitment to innovation, Solvo Biotechnology continuously expands its offerings, launching 10-20 new products and services annually based on the latest advancements in drug transporter science. Their expertise encompasses a variety of transporter-related studies, including drug-drug interactions and metabolic services, tailored to meet the needs of the pharmaceutical industry and regulatory agencies like the FDA and EMA. Generated from the website

IMARA Security Corporation is a Boston-based company that is dedicated to advancing medicine and restoring lives for people with cancer. With a team of experienced drug hunters, they specialize in the discovery and development of small molecule kinase inhibitors to enhance efficacy, combat resistance, and improve safety and patient convenience. Driven by their mission and passion, IMARA Security Corporation aims to help individuals with cancer not only live longer but also live better. Their innovative approach focuses on developing novel insights and precision therapeutics through the creation of kinase inhibitors that offer better selectivity, combinability, and the ability to address brain metastases.Generated from the website